The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension
Clinical Gastroenterology and Hepatology · 2023-07 · 21 (7) · 1854-1863.e10
DOI: 10.1016/j.cgh.2022.09.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-07. Verfasst von Mathias Jachs und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Hepatic Hemodynamic La…. Hauptthemen laut MEDLINE: Esophageal and Gastric Varices, Elasticity Imaging Techniques, Hypertension, Portal, Liver Diseases, Alcoholic. Die Arbeit wurde bisher 81-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND & AIMS: Baveno VII proposed liver stiffness measurement (LSM)/platelet count (PLT)-based criteria ('ruled out,' LSM ≤15 kPa plus PLT ≥150 G/L; 'ruled in': LSM ≥25 kPa) for clinically significant portal hypertension (CSPH) in compensated advanced chronic liver disease (cACLD). However, a substantial proportion of patients remains 'unclassified.' METHODS: Patients with evidence of cACLD (LSM ≥10 kPa) undergoing hepatic venous pressure gradient (HVPG) measurement at the Vienna General Hospital 2004 to 2021 (derivation [2004-2016], n = 221; validation [2017-2021], n = 81) were included. The performance of noninvasive tests (NITs) including von Willebrand factor antigen to PLT ratio (VITRO) for the detection of CSPH (HVPG ≥10 mmHg) were evaluated. RESULTS: Overall, viral hepatitis was the predominant (50.7%) etiology, followed by alcoholic liver disease (15.2%) and nonalcoholic steatohepatitis (13.2%); CSPH prevalence was 62.3%. In the derivation cohort, 45.7% were 'unclassified' according to Baveno VII criteria; in this group, VITRO showed an excellent diagnostic performance for the detection of CSPH (area under the receiver operating curve, 0.909; 95% confidence interval, 0.823-0.965). VITRO ≤1.5 and ≥2.5 ruled out (sensitivity, 97.7%; negative predictive value, 97.5%) and ruled in (specificity, 94.7%; positive predictive value, 91.2%), respectively, CSPH in patients who were 'unclassifiable' by Baveno VII criteria. The application of a sequential Baveno VII-VITRO algorithm reallocated 73% and 70% of 'unclassified' patients to the 'ruled in' and 'ruled out' group, respectively, while maintaining high sensitivity and negative predictive value and specificity and positive predictive value in the derivation and validation cohort, respectively. No patient allocated to the 'CSPH ruled out' group by the Baveno VII-VITRO algorithm developed decompensation within 5 years, whereas 5-year decompensation rates were negligible (4%) and substantial (23.9%) among 'unclassified' and 'CSPH ruled in' patients, respectively. CONCLUSIONS: The sequential application of VITRO in patients with cACLD who were 'unclassifiable' with regard to CSPH by Baveno VII criteria substantially decreased the number of 'unclassifiable' patients to
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine…
- Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
- Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
Zitieren
APA
Jachs, M., Hartl, L., Simbrunner, B., Bauer, D., Paternostro, R., Scheiner, B., Balcar, L., Semmler, G., Stättermayer, A. F., Pinter, M., Quehenberger, P., Trauner, M., Reiberger, T., & Mandorfer, M. (2023). The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension. Clinical Gastroenterology and Hepatology, 21(7), 1854-1863.e10. https://doi.org/10.1016/j.cgh.2022.09.032
Vancouver
Jachs M, Hartl L, Simbrunner B, Bauer D, Paternostro R, Scheiner B, et al. The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension. Clinical Gastroenterology and Hepatology. 2023;21(7):1854-1863.e10. doi:10.1016/j.cgh.2022.09.032
BibTeX
@article{Jachs2023,
author = {Jachs, Mathias and Hartl, Lukas and Simbrunner, Benedikt and Bauer, David and Paternostro, Rafael and Scheiner, Bernhard and Balcar, Lorenz and Semmler, Georg and Stättermayer, Albert Friedrich and Pinter, Matthias and Quehenberger, Peter and Trauner, Michael and Reiberger, Thomas and Mandorfer, Mattias},
title = {The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension},
journal = {Clinical Gastroenterology and Hepatology},
year = {2023},
volume = {21},
number = {7},
pages = {1854--1863.e10},
doi = {10.1016/j.cgh.2022.09.032}
}
EUVIMED